IMPAACT Studies in Development

The study you are looking for is in protocol development.

As the study protocol reaches Version 1.0, a study page will be developed.

  Study Number
Study Title Status



Phase I/II, Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of Clade C ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59® in African Infants

In Development



Protecting Households on Exposure to Newly Diagnosed Index Multidrug-Resistant TB Patients (PHOENIx)

In Development



Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression among Youth Living with HIV in the United States

In Development



A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and Uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection

In Development



A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Anti-Mycobacterial Activity of Bedaquiline in Combination with Optimized Individualized Multi-Drug Resistant Tuberculosis (MDR-TB) Therapy for the Treatment of HIV-Uninfected and Infected Children and Adolescents with MDR-TB Disease

In Development

Return to the full list of studies

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.